本页面由Tiger Trade Technology Pte. Ltd.提供服务

Relmada Therapeutics, Inc.

3.51
+0.12003.54%
盘前:3.520.0100+0.28%05:30 EDT
成交量:142.37万
成交额:492.82万
市值:3.76亿
市盈率:-3.77
高:3.54
开:3.39
低:3.32
收:3.39
52周最高:8.00
52周最低:1.80
股本:1.07亿
流通股本:8,263.90万
量比:0.88
换手率:1.72%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-1.4535
净资产收益率:-55.66%
总资产收益率:-32.39%
市净率:1.82
市盈率(LYR):-2.41

数据加载中...

2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/17

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2023/01/05

重要事件披露

8-K - Current report
2022/12/28

重要事件披露

8-K - Current report
2022/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals